NCT01159301 2013-09-19Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid LeukemiaNational Cancer Institute (NCI)Phase 1 Terminated44 enrolled